Correlation Between Danske Invest and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Danske Invest and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Danske Invest and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Danske Invest Europa and Genmab AS, you can compare the effects of market volatilities on Danske Invest and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Danske Invest with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Danske Invest and Genmab AS.

Diversification Opportunities for Danske Invest and Genmab AS

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Danske and Genmab is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Danske Invest Europa and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Danske Invest is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Danske Invest Europa are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Danske Invest i.e., Danske Invest and Genmab AS go up and down completely randomly.

Pair Corralation between Danske Invest and Genmab AS

Assuming the 90 days trading horizon Danske Invest Europa is expected to generate 0.44 times more return on investment than Genmab AS. However, Danske Invest Europa is 2.26 times less risky than Genmab AS. It trades about 0.04 of its potential returns per unit of risk. Genmab AS is currently generating about 0.0 per unit of risk. If you would invest  11,495  in Danske Invest Europa on January 26, 2024 and sell it today you would earn a total of  1,015  from holding Danske Invest Europa or generate 8.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy62.02%
ValuesDaily Returns

Danske Invest Europa  vs.  Genmab AS

 Performance 
       Timeline  
Danske Invest Europa 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Danske Invest Europa are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Danske Invest is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Genmab AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Danske Invest and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Danske Invest and Genmab AS

The main advantage of trading using opposite Danske Invest and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Danske Invest position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Danske Invest Europa and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk